Modeling household dynamics on Respiratory Syncytial Virus (RSV)

Modeling household dynamics on Respiratory Syncytial Virus (RSV)

Respiratory Syncytial Virus (RSV) is the most common cause of respiratory tract infection in infants and children and shows increasing trend among elderly people worldwide. In many developing country settings, population and household structures have gone through some significant changes in the past...

Descrición completa

Detalles Bibliográficos
Main Authors:	Mahikul, W, White, L, Poovorawan, K, Soonthornworasiri, N, Sukontamarn, P, Chanthavilay, P, F Medley, G, Pan-Ngum, W
Formato:	Journal article
Idioma:	English
Publicado:	Public Library of Science 2019

Títulos similares

Modeling household dynamics on Respiratory Syncytial Virus (RSV).
por: Wiriya Mahikul, et al.
Publicado: (2019-01-01)

Modelling population dynamics and seasonal movement to assess and predict the burden of melioidosis
por: Mahikul, W, et al.
Publicado: (2019)

A population dynamic model to assess the diabetes screening and reporting programs and project the burden of undiagnosed diabetes in Thailand
por: Mahikul, W, et al.
Publicado: (2019)

Modelling population dynamics and seasonal movement to assess and predict the burden of melioidosis.
por: Wiriya Mahikul, et al.
Publicado: (2019-05-01)

Pathobiology of Respiratory Syncytial Virus (RSV)
por: Ralph A. Tripp, et al.
Publicado: (2020-07-01)

Respiratory Syncytial Virus (RSV) Update
por: Leonard R. Krilov, et al.
Publicado: (2022-09-01)

Model evaluation of target product profiles of an infant vaccine against respiratory syncytial virus (RSV) in a developed country setting
por: Kinyanjui, T, et al.
Publicado: (2020)

The transmission dynamics of groups A and B human respiratory syncytial virus (hRSV) in England and Wales and Finland: seasonality and cross-protection.
por: White, L, et al.
Publicado: (2005)

Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication
por: Jackelyn Murray, et al.
Publicado: (2022-04-01)

The transmission dynamics of groups A and B human respiratory syncytial virus (hRSV) in England & Wales and Finland: seasonality and cross-protection
por: White, L, et al.
Publicado: (2005)

Prevention and Treatment Strategies for Respiratory Syncytial Virus (RSV)
por: Dvir Gatt, et al.
Publicado: (2023-01-01)

Predicting the relative impacts of maternal and neonatal respiratory syncytial virus (RSV) vaccine target product profiles: A consensus modelling approach.
por: Pan-Ngum, W, et al.
Publicado: (2016)

Model evaluation of target product profiles of an infant vaccine against respiratory syncytial virus (RSV) in a developed country setting
por: Timothy Kinyanjui, et al.
Publicado: (2020-04-01)

The Development of Animal Models for Respiratory Syncytial Virus (RSV) Infection and Enhanced RSV Disease
por: Gengxin Zhang, et al.
Publicado: (2024-10-01)

Epidemiological changes of respiratory syncytial virus (RSV) infections in Israel.
por: Shira Hirsh, et al.
Publicado: (2014-01-01)

Polymyalgia rheumatica following respiratory syncytial virus (RSV) vaccination
por: Mohamad El Labban, et al.
Publicado: (2024-06-01)

Perinatal Lamb Model of Respiratory Syncytial Virus (RSV) Infection
por: Mark R. Ackermann, et al.
Publicado: (2012-10-01)

Reducing respiratory syncytial virus (RSV) hospitalization in a lower-income country by vaccinating mothers-to-be and their households
por: Samuel PC Brand, et al.
Publicado: (2020-03-01)

Effects of formalin-inactivated respiratory syncytial virus (FI-RSV) in the perinatal lamb model of RSV.
por: Rachel J Derscheid, et al.
Publicado: (2013-01-01)

Antibody gene transfer for prophylaxis of respiratory syncytial virus (RSV) infection
por: Antepowicz, A, et al.
Publicado: (2018)

Monoterpene-Containing Substituted Coumarins as Inhibitors of Respiratory Syncytial Virus (RSV) Replication
por: Tatyana M. Khomenko, et al.
Publicado: (2021-12-01)

Respiratory syncytial virus (RSV) bronchiolitis: comparative study of RSV groups A and B infected children
por: Selir M. Straliotto, et al.
Publicado: (1994-03-01)

Respiratory syncytial virus (RSV) bronchiolitis: comparative study of RSV groups A and B infected children
por: Selir M. Straliotto, et al.
Publicado: (1994-03-01)

Effects of palivizumab prophylaxis on respiratory syncytial virus (RSV) infections in Montenegro
por: Envera Lekic, et al.
Publicado: (2024-05-01)

COVID-19 Lesson for Respiratory Syncytial Virus (RSV): Hygiene Works
por: Andrea Gastaldi, et al.
Publicado: (2021-12-01)

Immune Prophylaxis Targeting the Respiratory Syncytial Virus (RSV) G Protein
por: Harrison C. Bergeron, et al.
Publicado: (2023-04-01)

Anti-RSV Peptide-Loaded Liposomes for the Inhibition of Respiratory Syncytial Virus
por: Sameer Joshi, et al.
Publicado: (2018-05-01)

Defining the timing of respiratory syncytial virus (RSV) outbreaks: an epidemiological study
por: Enders Martin, et al.
Publicado: (2005-03-01)

Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B.
por: Anne M Hause, et al.
Publicado: (2017-01-01)

Model-based estimates of transmission of respiratory syncytial virus within households
por: Ivy K. Kombe, et al.
Publicado: (2019-06-01)

Correction: Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B.
por: Anne M Hause, et al.
Publicado: (2017-01-01)

Modelling the household-level impact of a maternal respiratory syncytial virus (RSV) vaccine in a high-income setting
por: Patricia T. Campbell, et al.
Publicado: (2020-11-01)

New Inhibitors of Respiratory Syncytial Virus (RSV) Replication Based on Monoterpene-Substituted Arylcoumarins
por: Tatyana M. Khomenko, et al.
Publicado: (2023-03-01)

Priorities for developing respiratory syncytial virus (RSV) vaccines in different target populations
por: Drysdale, S, et al.
Publicado: (2020)

Impact of Respiratory Syncytial Virus (RSV) in Adults 60 Years and Older in Spain
por: Sara Jimeno Ruiz, et al.
Publicado: (2024-11-01)

Burden of respiratory syncytial virus (RSV) infection in Germany: a systematic review
por: Anahita Poshtiban, et al.
Publicado: (2024-08-01)

Pricey or priceless: cost-effectiveness of respiratory syncytial virus (RSV) prevention in infants
por: Xiao Li, et al.
Publicado: (2024-01-01)

Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants
por: Asunci&oacute;n Mej&iacute;as, et al.
Publicado: (2008-09-01)

Review of the Safety, Efficacy and Tolerability of Palivizumab in the Prevention of Severe Respiratory Syncytial Virus (RSV) Disease
por: O'Hagan S, et al.
Publicado: (2023-09-01)

Olfactomedin 4 Serves as a Marker for Disease Severity in Pediatric Respiratory Syncytial Virus (RSV) Infection.
por: H K Brand, et al.
Publicado: (2015-01-01)